BACKGROUND: Compliance with treatment is a sine qua non for successful treatment of
chronic conditions like hypertension. Fixed-dose combinations are designed to simplify the …

Background Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death
and disability worldwide, yet ASCVD risk factor control and secondary prevention rates …

Background Cardiovascular disease (CVD) is the leading cause of death and disability
worldwide, yet CVD risk factor control and secondary prevention rates remain low. A fixed …

While clinical trials demonstrate the benefits of blood pressure and cholesterol reduction,
medication adherence in clinical practice is problematic. We hypothesized that a single-pill …

At present dislipidemia and hypertension are considered as leading independent risk factors
of cardio-vascular pathology. Their effective treatment leads to significant decrease of …

Abstract Purpose of Review To summarize the recent evidence on the effectiveness and
safety of antihypertensive fixed-dose combination (FDC) medications, and to describe the …

Despite data on the importance of blood pressure control in preventing cardiovascular and
cerebrovascular events, only 34% of hypertensive patients have their blood pressure under …

Aims: We assessed whether a novel programme to evaluate/communicate predicted
coronary heart disease (CHD) risk could lower patients' predicted Framingham CHD risk vs …

Heart failure remains among the most prevalent and burdensome medical conditions in the
United States. With increasing awareness regarding resource use and costs of care, there …

Background Clinical management of two key modifiable risk factors for cardiovascular
disease (CVD), hypertension and dyslipidemia, has evolved considerably over the past 40 …